Opendata, web and dolomites

ClearPEMplus

Enhanced Silicon Photomultiplier-based detectors for high-resolution Positron Emission Mammography.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ClearPEMplus project word cloud

Explore the words cloud of the ClearPEMplus project. It provides you a very rough idea of what is the project "ClearPEMplus" about.

dense    silicon    body    positive    complement    pet    implies    clearpem    emission    fold    enhanced    larger    outcome    healthcare    million    elaboration    innovative    commercialization    additional    clinics    imaging    scanners    critical    mm    exams    clinical    single    designed    sound    detecting    screening    chain    effect    hospitals       planning    marketing    beneficial    sensitivity    women    market    strategy    detector    tumours    history    solid    implants    lesions    housing    scanner    industrialization    survival    specificity    unnecessary    exact    rate    suffer    spatial    supply    operation    localization    positron    breast    battle    extreme    mammography    circuits    electronics    replying    young    staging    tumor    detection    complete    asics    establishing    petsys    performing    5cm    signal    departments    technique    situations    model    removal    distress    business    module    device    light    cure    plan    photodetector    scarce    read    sipm    resolution    small    hospital    cancer    tomography    trials    tailoring    false   

Project "ClearPEMplus" data sheet

The following table provides information about the project.

Coordinator
PETSYS ELECTRONICS - MEDICAL PET DETECTORS SA 

Organization address
address: TAGUSPARK EDIFICIO TECNOLOGIA I 26
city: PORTO SALVO
postcode: 2740 122
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://www.petsyselectronics.pt
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PETSYS ELECTRONICS - MEDICAL PET DETECTORS SA PT (PORTO SALVO) coordinator 50˙000.00

Map

 Project objective

Breast cancer affects more than 1.7 million women each year in Europe. Early detection and exact staging (single or multi-localization) is of extreme importance for improving the survival rate and cure outcome, and tailoring the operation (tumor or whole-breast removal). Currently mammography is the technique of choice for breast cancer screening, with positive cases addressed to further exams. Positron Emission Tomography (PET) imaging is beneficial to complement mammography in many situations: screening of critical cases with cancer history, detection in young women with dense breast or silicon implants, and to evaluate the effect of a cure. However whole-body PET scanners suffer of scarce sensitivity and are effective only in detecting tumours larger than 1-1.5cm. PETsys Electronics has designed and developed an innovative detector module for PET scanner based on the SiPM photodetector, a solid state device with enhanced sensitivity to low–light signal, that is read out by their novel highly integrated Application Specific Integrated Circuits (ASICs). The housing is specifically designed for breast cancer detection. Currently, ClearPEM is the only PET breast scanner based on the SiPM photodetector, which allows to provide a 10-fold larger sensitivity than whole body PET scanner. The improved spatial resolution enables to identify breast lesions as small as 1-2 mm. ClearPEM addresses the market of hospitals and clinics replying to their need of enhancing the specificity of mammography screening in breast cancer detection to battle the increasing rate of false-positive results, which implies additional cost for the healthcare system and unnecessary distress for women. The Phase 1 project will be focused on establishing a complete supply chain, a sound business model and commercialization strategy, a planning of all activities for performing the clinical trials in hospital departments, as well as the elaboration of an industrialization and marketing plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLEARPEMPLUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLEARPEMPLUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More